['angina pectoris', 'myocardial infarction', 'reperfusion injury', 'coronary heart disease']
['glp-1', 'placebo']

        Inclusion criteria:

          -  Undergoing elective PCI

          -  Age over 18

          -  Able to give informed consent

        Exclusion criteria:

          -  Severe co-morbidity (expected life expectancy < 6 months)

          -  Nicorandil, glibenclamide, sitagliptin, vildagliptin, saxagliptin, linagliptin,
             liraglutide, exenatide and insulin use

          -  Women of child bearing age

          -  Breast-feeding women

          -  Myocardial infarction within the previous 3 months

          -  Baseline elevation of Troponin I before PCI

          -  Chronic Renal Impairment (serum creatinine > 160 μmol/l)
      